Skip to main content
. 2021 Jan 15;11:592304. doi: 10.3389/fneur.2020.592304

Table 2.

Comorbidities in patients treated with ocrelizumab (n = 70).

Comorbidity N patients
Bipolar disease 1
Cerebral palsy 1
Chronic migraine 1
Diabetes mellitus 2
Heart disease 2
Hepatitis B inactive carrier 1
Hodgkin's lymphoma in remission 1
Hypertension 2
Morbid obesity 2
Pituitary adenoma 1
Psoriasis 1
Thrombocythemia 1
Uveitis 1